Details
Device typeGlycated haemoglobin (HbA1c) IVD, reagent: A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of glycated haemoglobin (HbA1c), also known as glycosylated haemoglobin in a clinical specimen.
FDA categoryAssay, Glycosylated Hemoglobin
Device ID05055273203554
Catalog numberHA3450
AvailabilityPrescription
Single useYes
MRI safetyLabeling does not contain MRI Safety Information